| Global emission hotspots of coal power generation C Oberschelp, S Pfister, CE Raptis, S Hellweg Nature Sustainability 2 (2), 113-121, 2019 | 211 | 2019 |
| Global thermal pollution of rivers from thermoelectric power plants CE Raptis, MTH van Vliet, S Pfister Environmental Research Letters 11 (10), 104011, 2016 | 146 | 2016 |
| Balancing clean water-climate change mitigation trade-offs S Parkinson, V Krey, D Huppmann, T Kahil, D McCollum, O Fricko, ... Environmental Research Letters 14 (1), 014009, 2019 | 88 | 2019 |
| Global freshwater thermal emissions from steam-electric power plants with once-through cooling systems CE Raptis, S Pfister Energy 97, 46-57, 2016 | 71 | 2016 |
| Biodiversity impacts from salinity increase in a coastal wetland MJ Amores, F Verones, C Raptis, R Juraske, S Pfister, F Stoessel, A Antón, ... Environmental science & technology 47 (12), 6384-6392, 2013 | 66 | 2013 |
| Assessing the environmental impacts of freshwater thermal pollution from global power generation in LCA CE Raptis, JM Boucher, S Pfister Science of the Total Environment 580, 1014-1026, 2017 | 48 | 2017 |
| Investigating the relationship between toxicity and organic sum-parameters in kraft mill effluents CE Raptis, R Juraske, S Hellweg Water research 66, 180-189, 2014 | 17 | 2014 |
| Water in life cycle assessment—50th Swiss discussion forum on life cycle assessment—Zürich, 4 December 2012 DM Tendall, C Raptis, F Verones The International Journal of Life Cycle Assessment 18, 1174-1179, 2013 | 13 | 2013 |
| The greenhouse gas emissions, water consumption, and heat emissions of global steam-electric power production: a generating unit level analysis and database CE Raptis, C Oberschelp, S Pfister Environmental Research Letters 15 (10), 104029, 2020 | 10 | 2020 |
| Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases CE Raptis, CT Berger, A Ciurea, DO Andrey, C Polysopoulos, P Lescuyer, ... Frontiers in Immunology, 5961, 2022 | 9 | 2022 |
| Footprints and safe operation space: walk the line? S Pfister, C Raptis Environmental science & technology 48 (16), 8935-8935, 2014 | 6 | 2014 |
| Immunogenicity of mRNA COVID-19 vaccines at 4 and 12 weeks post full vaccination in patients with inflammatory rheumatic diseases C Raptis, D Andrey, C Berger, A Finckh, P Lescuyer, A Ciurea, T Maletic, ... Arthritis & Rheumatology (Hoboken) 73, 4083-4086, 2021 | 5 | 2021 |
| Susceptibility to COVID-19 and immunologic response to vaccination in patients with immune-mediated inflammatory diseases A Finckh, A Ciurea, CE Raptis, A Rubbert-Roth The Journal of Infectious Diseases 228 (Supplement_1), S13-S23, 2023 | 4 | 2023 |
| TH, & Pfister, S.(2016). Global thermal pollution of rivers from thermoelectric power plants CE Raptis, M van Vliet Environmental Research Letters 11, 104011, 0 | 3 | |
| Op0175 type of mRNA Covid-19 vaccine and treatment influence antibody Kinetics in patients with inflammatory rheumatic diseases CE Raptis, DO Andrey, C Polysopoulos, C Berger, A Ciurea, P Lescuyer, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 115-116, 2022 | 1 | 2022 |
| Risk of SARS-CoV-2 infection following 3-dose homologous BNT162b2 or mRNA-1273 in patients with inflammatory rheumatic diseases CE Raptis, C Polysopoulos, CT Berger, A Ciurea, DO Andrey, T Maletic, ... Swiss Medical Weekly 153, 11S-11S, 2023 | | 2023 |
| POS0547 RISK OF SARS-COV-2 INFECTION FOLLOWING THREE DOSES OF BNT162B2 OR MRNA-1273 IN PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES CE Raptis, C Polysopoulos, C Berger, A Ciurea, DO Andrey, P Lescuyer, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 539-539, 2023 | | 2023 |
| Increased humoral immune response after vaccination with mRNA-1273 vs BNT162b2 in patients with inflammatory rheumatic diseases CE Raptis, CT Berger, DO Andrey, C Polysopoulos, A Ciurea, P Lescuyer, ... Swiss Medical Weekly 152, 2S-2S, 2022 | | 2022 |
| Thermal pollution of freshwater bodies from global power generation CE Raptis ETH Zurich, 2017 | | 2017 |
